Found: 16
Select item for more details and to access through your institution.
Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 202, doi. 10.1111/bjh.18989
- By:
- Publication type:
- Article
The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.
- Published in:
- Cell Death & Differentiation, 2014, v. 21, n. 2, p. 247, doi. 10.1038/cdd.2013.123
- By:
- Publication type:
- Article
Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.
- Published in:
- Advances in Hematology, 2011, v. 2011, p. 1, doi. 10.1155/2011/142395
- By:
- Publication type:
- Article
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 5, p. 1103, doi. 10.1038/leu.2013.307
- By:
- Publication type:
- Article
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 980, doi. 10.1038/leu.2014.24
- By:
- Publication type:
- Article
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 823, doi. 10.1038/leu.2013.283
- By:
- Publication type:
- Article
E2F4 plays a key role in Burkitt lymphoma tumorigenesis.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 10, p. 2277, doi. 10.1038/leu.2012.99
- By:
- Publication type:
- Article
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 9, p. 2103, doi. 10.1038/leu.2012.83
- By:
- Publication type:
- Article
Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Identification of MNDA as a new marker for nodal marginal zone lymphoma.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 10, p. 1847, doi. 10.1038/leu.2009.108
- By:
- Publication type:
- Article
UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.94_2880
- By:
- Publication type:
- Article
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from the Spanish group GELTAMO.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 345, doi. 10.1002/hon.2439_93
- By:
- Publication type:
- Article
PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH-RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 188, doi. 10.1002/hon.2438_49
- By:
- Publication type:
- Article